Lysophosphatidylcholine
Lysophosphatidylcholines, also called lysolecithins, are a class of chemical compounds which are derived from phosphatidylcholines.
Overview
Lysophosphatidylcholines are produced within cells mainly by the enzyme phospholipase A2, which removes one of the fatty acid groups from phosphatidylcholine to produce LPC. Among other properties, they activate endothelial cells during early atherosclerosis. LPC also acts as a find-me signal, released by apoptotic cells to recruit phagocytes, which then phagocytose the apoptotic cells. Moreover, LPCs can be used in the lab to cause demyelination of brain slices and to mimic the effects of demyelinating diseases such as multiple sclerosis. LPCs are also known to stimulate phagocytosis of the myelin sheath and can change the surface properties of erythrocytes. LPC-induced demyelination is thought to occur through the actions of recruited macrophages and microglia which phagocytose nearby myelin. Invading T cells are also thought to mediate this process.Bacteria such as Legionella pneumophila utilize phospholipase A2 end-products to cause host cell apoptosis through cytochrome C release.
LPCs are present as minor phospholipids in the cell membrane and in the blood plasma. Since LPCs are quickly metabolized by lysophospholipase and LPC-acyltransferase, they last only briefly in vivo. By replacing the acyl-group within the LPC with an alkyl-group, alkyl-lysophospholipids were synthesized. These LPC analogues are metabolically stable, and several ALPs such as edelfosine, miltefosine and perifosine are under research and development as drugs against cancer and other diseases. Lysophosphatidylcholine processing has been discovered to be an essential component of normal human brain development: those born with genes that prevent adequate uptake suffer from lethal microcephaly. MFSD2a has been shown to transport LPC-bound polyunsaturated fatty acids, including DHA and EPA, across the blood-brain and blood-retinal barriers.
LPCs occur in many foods naturally. According to the third edition of Starch: Chemistry and Technology, lysophosphatidylcholine makes up about 70% of the lipids in oat starch.
Also, the anti-cancer abilities of synthetic LPC variants are special since they do not target the cell DNA but rather insert into the plasma membrane, causing apoptosis through the influencing of several signal pathways. Therefore, their effects are independent of the proliferation state of the tumor cell.